| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | Apr 24, 2024 | Sale | $28.90 | 3,963 | 114,531 | 343,156 | Apr 26, 2024, 05:18 PM | |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | Apr 17, 2024 | Sale | $29.06 | 9,827 | 285,554 | 349,344 | Apr 19, 2024, 06:06 PM | |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | Feb 22, 2024 | Sale | $36.15 | 2,134 | 77,144 | 301,968 | Feb 23, 2024, 04:18 PM | |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | Jan 26, 2024 | Sale | $37.92 | 3,027 | 114,778 | 304,148 | Jan 29, 2024, 04:12 PM | |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | Nov 22, 2023 | Sale | $32.78 | 3,252 | 106,598 | 307,253 | Nov 24, 2023, 02:41 PM | |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | Oct 25, 2023 | Sale | $34.66 | 4,107 | 142,349 | 310,381 | Oct 27, 2023, 04:04 PM | |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | Aug 24, 2023 | Sale | $20.30 | 12,286 | 249,406 | 314,489 | Aug 25, 2023, 05:05 PM | |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | Jul 26, 2023 | Sale | $21.63 | 3,917 | 84,725 | 326,774 | Jul 27, 2023, 04:33 PM | |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | Apr 25, 2023 | Sale | $16.29 | 2,633 | 42,892 | 330,691 | Apr 26, 2023, 04:08 PM | |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | Jan 26, 2023 | Sale | $18.51 | 10,156 | 187,988 | 245,660 | Jan 27, 2023, 07:20 AM | |
| FLXN | Flexion Therapeutics Inc | Levine Mark S. | General Counsel | Nov 19, 2021 | Option Exercise | $8.50 | 133,486 | 1,134,631 | 0 | Nov 19, 2021, 10:08 AM | |
| FLXN | Flexion Therapeutics Inc | Levine Mark S. | General Counsel | Jul 19, 2021 | Sale | $6.45 | 3,945 | 25,445 | 133,486 | Jul 20, 2021, 08:45 PM | |
| FLXN | Flexion Therapeutics Inc | Levine Mark S. | General Counsel | Jan 05, 2021 | Sale | $11.13 | 6,829 | 76,007 | 107,431 | Jan 07, 2021, 05:52 PM | |
| FLXN | Flexion Therapeutics Inc | Levine Mark S. | General Counsel | Jun 22, 2020 | Option Exercise | $10.83 | 1,023 | 11,079 | 75,510 | Jun 24, 2020, 04:12 PM | |
| FLXN | Flexion Therapeutics Inc | Levine Mark S. | General Counsel | Jun 21, 2019 | Option Exercise | $9.81 | 1,213 | 11,900 | 46,273 | Jun 24, 2019, 04:14 PM | |
| FLXN | Flexion Therapeutics Inc | Levine Mark S. | General Counsel | Jan 03, 2019 | Sale | $12.36 | 734 | 9,072 | 9,060 | Jan 04, 2019, 05:12 PM | |
| FLXN | Flexion Therapeutics Inc | Levine Mark S. | General Counsel | Jun 20, 2018 | Option Exercise | $21.22 | 539 | 11,438 | 8,872 | Jun 22, 2018, 04:30 PM | |
| NERV | Minerva Neurosciences, Inc. | Levine Mark S. | SVP,General Counsel & Sec. | Jun 01, 2017 | Option Exercise | $5.19 | 17,500 | 90,825 | 17,500 | Jun 05, 2017, 04:33 PM | |
| NERV | Minerva Neurosciences, Inc. | Levine Mark S. | SVP,General Counsel & Sec. | Jun 01, 2017 | Sale | $11.00 | 17,500 | 192,500 | 0 | Jun 05, 2017, 04:33 PM | |
| NERV | Minerva Neurosciences, Inc. | Levine Mark S. | SVP,General Counsel & Sec. | Jan 04, 2017 | Option Exercise | $4.72 | 17,500 | 82,545 | 17,500 | Jan 06, 2017, 04:28 PM | |
| NERV | Minerva Neurosciences, Inc. | Levine Mark S. | SVP,General Counsel & Sec. | Jan 04, 2017 | Sale | $12.00 | 17,500 | 210,000 | 0 | Jan 06, 2017, 04:28 PM |
Menu